Blood test for spotting ovarian cancer in endometriosis
Part of Women’s health & pregnancy clinical trials.
This study tests a new blood-based marker to help doctors tell the difference between endometriosis and ovarian cancer that may be linked to endometriosis. It could help improve diagnosis before surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are female and 18 years or older.
- You have been newly diagnosed with endometriosis or a suspected ovarian cancer linked to endometriosis.
- You plan to have surgery for your condition.
- You are willing to give a blood sample for testing.
- You have not had chemo or pelvic radiation in the last 6 months.
- You have no other active cancer.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a new blood test can accurately detect endometriosis (tissue similar to uterine lining growing outside the uterus). You may qualify if you menstruate regularly, are between 14–49 years old, and either have confirmed endometriosis, had a negative laparoscopy (a scope procedure), or have no endometriosis symptoms.
This study tests a new blood test (HerResolve™) to see if it can accurately detect endometriosis in women who already have pelvic pain or abnormal bleeding and are scheduled for a diagnostic laparoscopy. If accurate, it could offer a less invasive way to diagnose endometriosis in the future.
This study collects blood and small tissue samples during planned gynecological surgery to better diagnose endometriosis and predict its course. It may help future patients by making diagnoses and outlook more accurate.
This study is testing whether a blood test based on tiny particles called exosomes can help predict if ovarian cancer will come back. It may help doctors plan better follow-up care.
This study is testing new blood tests that might help detect ovarian cancer earlier by looking for specific markers. It involves people with suspected ovarian cancer and healthy volunteers, and aims to improve how we diagnose the disease.
This study is testing a new blood test to help find ovarian cancer early in women who are at average risk. By joining, you may help improve early detection, which could lead to better outcomes.
Hear when a new Endometriosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.